Synbiobeta

Synbiobeta Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Synbiobeta, Biotechnology company, Pleasant Hill, CA.

Synthetic Biology Events & Industry Information
šŸŒ Global Synthetic Biology Conference
šŸ“… May 4-7, 2026 in San Jose
Join us!

tinyurl.com/2uc677rn Built With Biology is the premier innovation network for biological engineers, innovators, entrepreneurs, and investors who share a passion for using biology to build a better, more sustainable planet. We provide our community members with

personal and professional development support, as well as valuable opportunities for networking, partnership, collaboration, and education. Every year we host The Global Synthetic Biology Summit which showcases the cutting-edge developments in biology that are transforming how we fuel, heal, and feed the world. In addition, we stage a variety of other conferences, thought leader retreats, and local meet-ups throughout the year, in both the United States and around the world.

Paradromics has received FDA approval to expand the devices evaluated with its investigational brain-computer interface ...
09/05/2026

Paradromics has received FDA approval to expand the devices evaluated with its investigational brain-computer interface in the Connect-One clinical study. The new pathway could allow compatible laptops, tablets and phones to connect through its Convey system, supporting greater mobility, communication and digital independence for people with severe motor impairments.

https://www.businesswire.com/news/home/20260826858731/en/Paradromics-Receives-FDA-Approval-to-Expand-BCI-Access-to-Personal-Computing-Devices-in-Connect-One-Clinical-Study

Want to stay ahead in biotech? Subscribe to our newsletter for more šŸ§¬
https://www.syntheticbiologysummit.com/?utm_source=facebook&utm_medium=social&utm_campaign=digest-08.21.26&utm_content=text-link

Google DeepMind has piloted a double-blind evaluation system designed to make frontier AI testing more trustworthy. Usin...
09/05/2026

Google DeepMind has piloted a double-blind evaluation system designed to make frontier AI testing more trustworthy. Using a cryptographically secured environment, the process keeps confidential benchmark prompts hidden from Google while protecting Geminiā€™s model weights from evaluatorsā€”reducing benchmark contamination without exposing sensitive data.

https://deepmind.google/blog/piloting-the-worlds-first-double-blind-ai-evaluations/

Want to stay ahead in biotech? Subscribe to our newsletter for more šŸ§¬
https://www.syntheticbiologysummit.com/?utm_source=facebook&utm_medium=social&utm_campaign=digest-08.21.26&utm_content=text-link

Anthropic is opening 10,000 Claude subscription seats for scientists worldwide, offering free standard access and premiu...
09/05/2026

Anthropic is opening 10,000 Claude subscription seats for scientists worldwide, offering free standard access and premium plans at $15 per month for one year. Researchers may also apply for up to $50,000 in Claude credits per project, while access to Mythos-class models for life sciences is being developed with the US government.

https://www.techtimes.com/articles/325943/20260828/anthropic-opens-free-claude-scientists-biology-frontier-goes-through-washington.htm

Want to stay ahead in biotech? Subscribe to our newsletter for more šŸ§¬
https://www.syntheticbiologysummit.com/?utm_source=facebook&utm_medium=social&utm_campaign=digest-08.21.26&utm_content=text-link

Evonik is investing more than C$150 million in a new GMP manufacturing facility for lipid-based drug delivery in Vancouv...
09/04/2026

Evonik is investing more than C$150 million in a new GMP manufacturing facility for lipid-based drug delivery in Vancouver. Scheduled to begin production by the end of 2029, the facility will more than triple Evonikā€™s local capacity for vaccines, therapeutics and other advanced medicines.

https://www.prnewswire.com/news-releases/evonik-expands-lipid-based-drug-delivery-capabilities-with-new-gmp-manufacturing-facility-in-vancouver-302862185.html

Want to stay ahead in biotech? Subscribe to our newsletter for more šŸ§¬
https://www.syntheticbiologysummit.com/?utm_source=facebook&utm_medium=social&utm_campaign=digest-08.21.26&utm_content=text-link

Women are becoming more visible in biotech leadership, but representation does not always translate into equal influence...
09/04/2026

Women are becoming more visible in biotech leadership, but representation does not always translate into equal influence. Sarepta Therapeutics executive Dorian Readnour says progress should also be measured by who is heard, sponsored and trusted with important opportunities. Sponsored content created and paid for by Aria. Reuters News and Reuters Plus were not involved in its production.

https://www.reuters.com/plus/biotech-has-more-women-leaders-old-double-standards-persist-executive-says

Want to stay ahead in biotech? Subscribe to our newsletter for more šŸ§¬
https://www.syntheticbiologysummit.com/?utm_source=facebook&utm_medium=social&utm_campaign=digest-08.21.26&utm_content=text-link

Scientists at Kindred Companion Sciences have used CRISPR to create two beagles that do not produce Can f 1, the protein...
09/04/2026

Scientists at Kindred Companion Sciences have used CRISPR to create two beagles that do not produce Can f 1, the protein responsible for many human allergic reactions to dogs. The puppies, Alfie and Bailey, showed no clinically apparent health abnormalities at the time reported. However, the research remains an early proof of conceptā€”not evidence that the approach is ready for widespread use.

https://www.aaha.org/trends-magazine/publications/team-uses-crispr-editing-to-create-non-allergenic-dogs/

Want to stay ahead in biotech? Subscribe to our newsletter for more šŸ§¬
https://www.syntheticbiologysummit.com/?utm_source=facebook&utm_medium=social&utm_campaign=digest-08.21.26&utm_content=text-link

Carterraā€™s high-throughput SPR technology supported one of the largest reported wet-lab validations of AI-designed prote...
09/04/2026

Carterraā€™s high-throughput SPR technology supported one of the largest reported wet-lab validations of AI-designed proteins. Anthropic used Claude to design protein binders across 15 targets, while Twist Bioscience and Adaptyv independently tested the designs using Carterra platforms. The work highlights how high-throughput laboratory systems can help experimental validation keep pace with rapidly advancing AI design.

https://pharmatimes.com/news/carterra-supports-ai-designed-protein-study-with-ht-spr-platforms/

Want to stay ahead in biotech? Subscribe to our newsletter for more šŸ§¬
https://www.syntheticbiologysummit.com/?utm_source=facebook&utm_medium=social&utm_campaign=digest-08.21.26&utm_content=text-link

LambdaVision is taking its space-based biotechnology program beyond the International Space Station for the first time t...
09/04/2026

LambdaVision is taking its space-based biotechnology program beyond the International Space Station for the first time through an October 2026 mission with Helogen. Using Helogenā€™s autonomous HEL-IOS platform, the mission will test bacteriorhodopsinā€”the light-sensitive protein used in LambdaVisionā€™s artificial retinaā€”and generate data for future quality-control and manufacturing processes in low-Earth orbit.

https://www.businesswire.com/news/home/20260901195371/en/LambdaVision-Advances-Space-Based-Manufacturing-With-Its-First-Mission-Beyond-the-ISS

Want to stay ahead in biotech? Subscribe to our newsletter for more šŸ§¬
https://www.syntheticbiologysummit.com/?utm_source=facebook&utm_medium=social&utm_campaign=digest-08.21.26&utm_content=text-link

Transfyr has launched with $25 million in seed funding to build a physical AI platform that captures how laboratory work...
09/04/2026

Transfyr has launched with $25 million in seed funding to build a physical AI platform that captures how laboratory work is performed and converts it into machine-readable knowledge. Founded by Anna Marie Wagner and Renee Wegrzyn, the company aims to make scientific research more reproducible, transferable and ready for AI-powered automation. The round was led by General Catalyst with participation from leading science and technology investors.

https://www.businesswire.com/news/home/20260826235022/en/Transfyr-Launches-Physical-AI-Platform-for-Science-with-%2425M-Seed-Funding

Want to stay ahead in biotech? Subscribe to our newsletter for more šŸ§¬
https://www.syntheticbiologysummit.com/?utm_source=facebook&utm_medium=social&utm_campaign=digest-08.21.26&utm_content=text-link

UK venture capital investment reached Ā£14.4 billion in the first half of 2026, putting the market on course to potential...
09/04/2026

UK venture capital investment reached Ā£14.4 billion in the first half of 2026, putting the market on course to potentially surpass its 2021 record. Software, AI and biotechnology attracted much of the funding, with overseas investors driving most of the demand. Isomorphic Labs and Wayve led major fundraising activity, securing Ā£1.5 billion and Ā£945 million respectively in Q2.

https://www.ft.com/content/25121087-b57c-4a50-ae83-f09399e2e84d?syn-25a6b1a6=1

Want to stay ahead in biotech? Subscribe to our newsletter for more šŸ§¬
https://www.syntheticbiologysummit.com/?utm_source=facebook&utm_medium=social&utm_campaign=digest-08.21.26&utm_content=text-link

Address

Pleasant Hill, CA

Website

,

Alerts

Be the first to know and let us send you an email when Synbiobeta posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Synbiobeta:

Shortcuts

Share

Category